Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough
overview of the latest advances toward the development of therapeutics for Alzheimer's disease
along with the major hurdles that still must be overcome and potential solutions to these
problems. Despite the lack of progress toward developing therapeutics that can slow or stop the
progression of this disease important discoveries have been made and many promising approaches
are advancing in preclinical studies and clinical trials. This book outlines the special
challenges related to specific targets and approaches while presenting a realistic
comprehensive and balanced view of drug discovery and development in this area. Written by
international leaders in the field the book assesses prospects for the emergence of effective
agents and allows readers to better understand the challenges failures and future potential
for research in Alzheimer's disease. This book is a valuable resource to academic scientists
carrying out translational research in Alzheimer's disease industrial scientists engaged in
Alzheimer's drug discovery executives in biopharmaceutical companies making strategic
decisions regarding the direction of internal research and potential outside partnerships and
graduate-level students pursuing courses on Alzheimer's therapeutics.
